eCommons@AKU
Internal Medicine, East Africa

Medical College, East Africa

7-2019

Comparison of the Sequential Organ Failure Assessment (SOFA)
and Quick SOFA Scores in Predicting in-Hospital Mortality among
Adult Critical Care Patients with Suspected Infection
Mohammed A. Said
Wangari Siika
Vitalis Mung’ayi
Reena Shah

Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med
Part of the Critical Care Commons

ISSN: 2474-3674

Said et al. Int J Crit Care Emerg Med 2019, 5:084
DOI: 10.23937/2474-3674/1510084
Volume 5 | Issue 4
Open Access

International Journal of

Critical Care and Emergency Medicine
Original Article

Comparison of the Sequential Organ Failure Assessment (SOFA) and
Quick SOFA Scores in Predicting in-Hospital Mortality among Adult
Critical Care Patients with Suspected Infection
Mohammed A Said, MBChB, MPH1, Wangari-Waweru Siika, MBChB1, Vitalis Mung’ayi, MBChB2 and
Reena Shah, MBChB, MRCP, MSc1*
Department of Internal Medicine, Aga Khan University Hospital, Kenya
Department of Anesthesia, Aga Khan University Hospital, Kenya

1
2

Check for
updates

*Corresponding author: Prof. Reena Shah, MBChB, MRCP, MSc, Associate Professor, Department of Internal Medicine,
Aga Khan University Hospital, Nairobi, Kenya, Tel: 254735338003
Abstract
Introduction: Sepsis is global health priority and the leading cause of death in critical care. The SEPSIS 3 criteria
introduced in 2016 is the latest tool in diagnosing sepsis.
It uses SOFA and qSOFA scores in place of the SIRS criteria for better ability to predict mortality in patients with
suspected infections. The performance of these scores in
critical care units outside high-income countries remains
largely unknown.
Methods: We compared the performance of SOFA and
qSOFA in predicting the in-hospital mortality of an adult
critical care unit in Kenya. We conducted a retrospective
review of all patients admitted to the critical care units with
suspected infection between 1 January 2017 and 31 December 2017. A standardized electronic data collection tool
was be used to collect demographic, clinical and outcome
data on the participants. Area under the receiver operating
characteristic curves (AUROC) with 95% confidence intervals was used to compare SOFA and qSOFA.
Results: We enrolled 450 patients with a mean age of 56
years [SD ± 19.10] and 57.60% were male. Majority of the
patients, 352 (78.20%), presented through the emergency
department. Pneumonia was the commonest source of
infection 293 (65.10%). There were 92 deaths (mortality
rate of 20.44%). The majority of patients, 371 (82.44%)
manifested a SOFA score of ≥ 2 and 190 (42.22%) had a
qSOFA score of ≥ 2. SOFA score was superior in predicting
in hospital mortality compared to qSOFA with an AUROC
= 0.799 [0.752-0.846] vs. 0.694 [0.691-0.748, P < 0.001].

Conclusion: A SOFA score of two or more is better than
qSOFA score in predicting in-hospital mortality among
adult critical care patients with suspected infection. This
finding suggests that SOFA is an appropriate tool in the
initial diagnosis sepsis in critical care setting in a developing
country.
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Background
Sepsis is a life-threatening condition with organ dysfunction caused by a dysregulated host response to an
infection [1]. In 2016, there were an estimated 30 million cases of sepsis and 6 million deaths attributed to
sepsis globally [2]. The incidence of sepsis has increased
by 8.7% from 1979 to 2000. Sepsis is now the leading
cause of critical care mortality [2]. Furthermore, Sepsis
survivors have a higher risk for long-term physical, cognitive and psychosocial morbidity [3]. Sepsis is also a
costly condition with US$ 20 billion spending annually
in the USA alone [4]. In view of these, the World Health
Organization (WHO) declared sepsis a global health priority in 2017 [5].
Despite this health impact, defining sepsis has remained difficult, hindered by a variable clinical presentation
and absence of a reliable diagnostic test [1]. In March
2016, the third international consensus definition for
sepsis and septic shock (SEPSIS 3) was published [1].
SEPSIS 3 defined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection. Organ dysfunction is an increase in the sequential (sepsis-related) organ failure assessment (SOFA)
score of two points or more. Septic shock is a subset of
sepsis with profound circulatory, cellular and metabolic
abnormalities associated with a greater risk of mortality
(> 40%) than sepsis alone. Septic shock is defined clinically by vasopressor requirement to maintain a Mean
Arterial Pressure (MAP) of > 65 mmHg and a serum
lactate > 2 millimole per liter (mmol/l) in the absence of
hypovolemia [1].
The SEPSIS 3 definition task force also developed
a new simple measure for rapidly identifying patients
with sepsis termed quick SOFA (qSOFA) incorporating
systolic blood pressure < 100 mmHg, altered mental
status and a respiratory rate of 22 breaths per min or
greater. A score of two or more points in patients with
presumed infection defines sepsis. The qSOFA does not
require laboratory tests and therefore offers a simple
bedside assessment for sepsis, potentially useful in low
resource settings.
This new definition (SEPSIS 3) is the most up-to-date view of sepsis, incorporating the advances in the understanding of sepsis pathobiology, especially in distinguishing sepsis from uncomplicated infection. This task
force definition also promises to offer easily measurable
clinical criteria that captures the essence of sepsis and
allows for a more accurate appreciation of the scale of
the sepsis problem globally [1].
However, there was no involvement of Low-income
countries in the making of the SEPSIS 3 definition.
The taskforce of the SEPSIS 3 acknowledged this as a
limitation and encouraged further research in these
regions, especially in the performance of the new SOFA
and qSOFA scores in patients with suspected infections
in Low income countries [1].
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To the best of our knowledge, there are no studies
assessing the performance of the new SOFA and qSOFA scores in low income to middle-income countries
in Africa. Generally, there is paucity of data on sepsis
from developing countries particularly from sub-Saharan Africa where there is a larger population at risk of
sepsis in sub-Saharan Africa due to the high burden of
HIV and other infectious diseases predisposing to sepsis
at a younger age compared to the high-income countries [6]. The infecting pathogens are also different [6].
Sub-Saharan Africa also has limited critical care capacity in these environments to manage sepsis, affecting
outcomes of sepsis patients. These factors make the
low-income countries distinctly different and a priority
region in sepsis research [7].

Methodology
Study aim
The primary aim of is to compare the performance of
the SOFA score and qSOFA score in predicting in-hospital mortality among patients with suspected infection in
a low-income country setting.

Study setting
We conducted this study at the Aga Khan University
Hospital, Nairobi (AKUH, N) a 258-bed capacity, private, nonprofit, premier teaching hospital offering tertiary
level and secondary level healthcare services to the people of East Africa. AKUH, N established in 1958 received the Joint Commission of International Accreditation
(JCIA) accreditation in 2013. AKUHN has over 35 beds
for critical care, one of the largest critical care capacities
in Nairobi city.

Study design
gn.

We used a retrospective cross-sectional study desi-

Study population
The study population were all adult patients admitted to the critical care units in the period 1st January
2017 to 31st December 2017. We included all patients
aged ≥ 18 and suspected infection at admission; defined
as those patients who have bodily fluids sampled for
cultures with or without receiving antimicrobials within
the first 24 hours of admission to the critical care units.
We excluded participants with incomplete data; defined
as cases without outcome data (alive or dead at hospital discharge) or lacked necessary data to complete the
SOFA and qSOFA score for the first 24 hours of admission to critical care.

Study procedure
The critical admission records were manually screened then checked against the electronic health record
using the inclusion criteria. Subsequently, a list of the all
cases of suspected sepsis with the patients’ identification numbers generated. Primary Outcome was all cause in-hospital mortality as confirmed from the hospital
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medical records and death register. Secondary outcome
was achieving a critical care length of stay of at least
three days. Similar to the original SEPSIS 3 study and
subsequent studies in other regions of the world that
have looked at performance of the SOFA and qSOFA.
The SOFA score includes laboratory variables (Partial
pressure of oxygen, platelet count, creatinine and bilirubin levels) and clinical variables (Glasgow coma scale
and hypotension).

racteristic curve (AUROC) with 95% confidence interval
was be used to determine discriminatory power of each
score. The Hanley and McNeil method compared the
differences in the AUROCs of the scores overall and in
the subgroup of sepsis patients. All statistical tests were
two sided and P value < 0.05 was considered significant.

Data management and analysis

There were 1790 admissions to the critical care units of AKUHN in the period 1 January 2017 to 31 December 2017. There were 844 patients meeting criteria for
suspected infections at admission, of these 394 patients
were excluded for various reasons as shown in Figure 1.
A total of 450 patients finally formed the study cohort.

We developed a data abstraction tool to extract variables of interest. Variables of interest included: Demographical information (age and sex), critical care length
of stay, and hospital length of stay, status at discharge (alive or deceased) from critical care and hospital,
clinical and laboratory variables for the calculation of
the SOFA and qSOFA scores. The scores for the first 24
hours of critical care admission were calculated and the
highest score in that first 24 hours taken. Trained research assistants abstracted the data electronically using
EPI INFO® software version 7.2.2.6. The principal investigator counter checked all the collected data at the
end of every week of data collection to make sure accuracy in data collection and compliance with the study
protocol.
After data collection and coding, the data moved
from to a password-secured Stata database for analysis.
For statistical analysis, descriptive quantitative variables
were reported using means (± Standard Deviation) or
medians (interquartile range (IQR)) according to their
distribution. Chi-square test compared categorical variables and Wilcoxon’s rank sum test compared continuous variables. Area under the receiver operating cha-

Results
Study participants

Demographic and clinical profiles of the cohort
The demographic and clinical profiles of the patients
are provided in Table 1 below. The age of the patients
ranged between 18 and 98 years with a mean age of 56
years [SD ± 19.10]. The majority were male 259 (57.6%).
Non-survivors were older (59 vs. 52 years, P = 0.002).
Majority of the patients, 352 (78.2%) came to the
critical care units through the emergency department.
The mortality rate was higher among patients referred
from other sources compared to the emergency
department (33.67% 16.76%, P < 0.001).
The most common comorbidity was diabetes mellitus, 123 (27.3%), followed by malignancy, 74 (16.5%). In
the study cohort, 40 (8.9%) were HIV positive. Patients
with liver disease and malignancy had a higher mortality, 7.3% vs. 15.2%, P = 0.05 and 11.7% vs. 34.8%, P <
0.001 respectively.

1790 Total Admissions to Critical Care

844 Total patients with suspected Infections at
admission

394 Excluded
104 Re-admissions
290 Missing files /outcome data

450- Total Patients included in the Analysis

Figure 1: Flow diagram showing the selection of study cohort.
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Table 1: Demographics and clinical characteristics.
All Patients

Survivors

Non-survivors

P value

(N = 450)

(N = 358)

(N = 92)

Age (Median(IQR))

54 (40-70.5)

52 (38-70)

59 (48-76)

0.002

Age, n (%)

8 (1.8%)

7 (2%)

1 (1.1%)

0.0680

			18-34 years

75 (16.7%)

68 (19%)

7 (7.6%)

			35-49 years

94 (20.9%)

75 (21%)

19 (20.7%)

			50-64 years

130 (28.9%)

100 (27.9%)

30 (32.6%)

			>= 65 years

143 (31.8%)

108 (30.2%)

35 (38.0%)

259 (57.6%)

201 (56.1%)

58 (63%)

191 (42.4%)

157 (43.9%)

34 (37%)

Demographics
Below 18 years

Gender:		Male
			Female
ICU Admission Source (N (%) :

0.232
0.001

Emergency departments

352 (78.2%)

293 (81.9%)

59 (64.1%)

Other

98 (22.7%)

65 (18.1%)

33 (35.9%)

Diabetes Mellitus

123 (27.3%)

96 (26.8%)

27 (29.4%)

0.826

Liver Disease

40 (8.9%)

26 (7.3%)

14 (15.2%)

0.040

Malignancy:

74 (16.5%)

42 (11.7%)

32 (34.8%)

< 0.001

			Metastatic solid tumor

26 (5.8%)

12 (3.3%)

14 (15.2%)

			Hematological

48 (10.7%)

30 (8.4%)

18 (19.6%)

PUD

10 (2.2%)

7 (2.0%)

3 (3.2%)

0.657

COPD

24 (5.3%)

17 (4.8%)

7 (7.6%)

0.524

AIDS

40 (8.9%)

29 (8.1%)

11 (11.9%)

0.481

Dementia

5 (1.1%)

4 (1.1%)

1 (1.1%)

0.986

Stroke

69 (16.2%)

55 (16.2%)

13 (15.1%)

0.769

Respiratory

293 (65.1%)

242 (67.6%)

51 (55.4%)

0.029

Renal/Urinary tract

102 (22.7%)

87 (24.3%)

15 (16.3%)

0.102

Blood stream

98 (21.8%)

69 (19.3%)

29 (31.5%)

0.011

Abdominal

49 (10.9%)

36 (10.1%)

13 (14.1%)

0.263

CNS

21 (4.7%)

19 (5.3%)

2 (2.2%)

0.274

127 (28.2%)

91 (25.4%)

36 (39.1%)

0.024

(Co-morbidities): (N (%))

Site of Infections:

Clinical Parameters
Temperature (> 38 or < 36 °C)
Heart Rate (> 90)

348 (97.2%)

259 (72.3%)

89 (96.7%)

0.001

White cell count (> 12 × 103/< 4 × 103)

242 (53.8%)

176 (49.2%)

66 (71.7%)

0.002

Lactate (≥ 2 mmol/l)

138 (30.7%)

79 (22.1%)

59 (64.1%)

0.0001

94 (20.9%)

59 (16.4%)

35 (38.0%)

< 0.001

			Escherichia coli

18 (19.1%)

14 (23.7%)

4 (11.4%)

			Klebsiella pneumonia

13 (13.8%)

8 (13.5%)

5 (14.3%)

6 (6.3%)

2 (3.39%)

4 (11.4%)

6 (6.3%)

2 (3.39%)

4 (11.4%)

Culture yield:
Most common organisms:

Coagulase negative Staphylococcus
			Staphylococcus aureus

PUD: Peptic Ulcer Disease; COPD: Chronic Obstructive Pulmonary Disease; AIDS: Acquired Immunodeficiency Syndrome.

The commonest sites of infection were respiratory
system, 293 (65.1%), followed by urinary tract 102
(22.7%) and bloodstream infection 98 (21.8%). The
patients with a respiratory source of infection had a
higher mortality (67.6% vs. 55.4%, P < 0.029). Patients
Said et al. Int J Crit Care Emerg Med 2019, 5:084

with bloodstream infections also had a higher mortality
(19.3% vs. 31.5%, P < 0.011). The same is reflected in
culture yield, with a higher mortality among those
with culture positive results (16.4% vs. 38%, P < 0.001).
Overall, 92 (20.9%) patients had a positive culture.
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Table 2: Positive cultures data.
Commonest microorganisms

Blood culture

Urine culture

Tracheal aspirate
culture

Wound swab
cultures

Total

Escherichia coli

10 (55.6%)

9 (50.0%)

2 (11.1%)

0 (0%)

18

Klebsiella pneumonia

7 (53.8%)

3 (23.1%)

3 (23.1%)

0 (0%)

13

Pseudomonas aeruginosa

2 (18.2%)

1 (9.1%)

5 (45.5%)

3 (27.3%)

11

Staphylococcus aureus

4 (66.7%)

0 (0%)

2 (%)

0 (0%)

6

Coagulase negative
Staphylococcus

6 (100%)

0 (0%)

0 (0%)

0 (0%)

6

Candida species

3 (60.0%)

2 (40.0%)

0 (0%)

0 (0%)

5

60
40
0

20

% of Mortality

80

100

SOFA scores

0

1

2

3

4

5

6

7

8

9 10 11 12 13 14 15 16 17 18 19 20 21

SOFA Score
No.of patients per score
28

50 45

51

56

45

34

36

27

15

14

14 13

8

7

2

0

1

0

2

0

1

Figure 2: Mortality at SOFA score on critical care admission among patients with infection.

5 10 15 20 25 30 35 40 45 50
0

% of Mortality

qSOFA scores

0
No.of patients per score
92

1
2
qSOFA score

3

167

49

141

Figure 3: Mortality by qSOFA score at critical care admission among patients with infection.
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The most common organisms isolated from blood
were Escherichia coli (29.5%), Klebsiella pneumonae
(2.13%) and Staphylococcus aureus (9.8%). Among
the isolated Escherichia coli, 41.4% were extended
spectrum β-lactamases producing (ESBL). Majority
55.2% were sensitive to most commonly used antibiotics including penicillins and cephalosporins.

Microbiological Data
Severity of illness and outcome
Of the 450 patients recruited, 371 patients (82.4%)
had a SOFA score of two or more and 190 (42.2%)
patients had qSOFA score of two or more Table 2. The
distribution of each score and relationship with inhospital mortality and critical care stay of three or more
days are presented in Figure 2 and Figure 3 below.
In hospital mortality was 24.53% and 34.21% for
patients with SOFA and qSOFA scores of two or more

respectively (P < 0.001). Non-survivors had a longer
critical care length of stay compared with survivors
(median length of stay of 3 days vs. 5 days, P < 0.008)
Table 3.

Score performance
Prediction of in-hospital mortality was significantly higher using SOFA (AUROC, 0.799 [95% CI, 0.752 to
0.846]) than qSOFA (AUROC, 0.694 [95% CI, 0.641 to
0.748]); all p < 0.001 (Figure 4). When considered in
conjunction with baseline prediction of mortality, SOFA
(AUROC, 0.822 [95% CI, 0.744-0.869]) outperformed
qSOFA (AUROC, 0.751 [95% CI, 0.695-80.7]) for prediction of in hospital mortality.
The superior performance of SOFA was not maintained in the secondary outcome of a critical care length of stay of three or more days, SOFA (AUROC, 0.658
[95% CI, 0.605-0.712]) vs. qSOFA (AUROC, 0.669 [95%

Table 3: Severity of illness and length of stay in critical care and hospital stay.
All Patients

Survivors

Non-survivors

P value

(N = 450)

(N = 358)

(N = 92)

371 (82%)

280 (75.5%)

91 (24.5%)

< 0.001

<2

78 (17.4%)

78 (21.8%)

0 (0%)

< 0.001

2-5

197 (44%)

173 (48.3%)

24 (26.4%)

6-10

126 (28%)

89 (24.9%)

37 (40.7%)

11-14

42 (9.4%)

17 (4.8%)

25 (27.5%)

>= 15

6 (1.3%)

1 (0.3%)

5 (5.5%)

QSOFA score (>= 2), n (%)

190 (42%)

125 (65.8%)

65 (34.2%)

< 0.001

Critical care stay >= 3 days (Secondary outcome)

284 (63%)

218 (60.9%)

66 (71.7%)

0.054

ICU length of stay, Median (IQR) days

4 (2-8)

3 (2-7)

5 (2-11)

0.008

Hospital length of stay, Median (IQR) days

8 (4-15)

8 (4-15)

7.5 (3-13)

0.130

Severity of illness on admission to ICU:
SOFA score (>= 2), n (%)

0.00

0.25

Sensitivity
0.50

0.75

1.00

SOFA Scores, n (%):

0.00

0.25

0.50
1-Specificity

qSOFA ROC area: 0.6943

0.75

1.00

SOFA ROC area: 0.7989

Figure 4: Crude AUROC-critical care mortality.
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CI, 0.621-0.717]).

Discussion
In this study comparing the performance of SOFA
score with qSOFA score in predicting in hospital mortality among critical care patients in a low-income country,
SOFA score was superior to qSOFA score. There was no
difference in the predicting prolonged critical care stay
between the SOFA and qSOFA scores.
Recent study by Seymour, et al. [6] in Pittsburg, USA
in 2016 showed SOFA was superior in discriminating for
in hospital mortality among critical care patients, with
an AUROC of 0.74 (95% CI 0.73-0.76) compared to qSOFA with a AUROC of 0.66 (95% CI, 064-0.68). In another
high income setting of Australia and New Zealand, Raith, et al. [8] also showed a SOFA to be superior to qSOFA
in predicting for in hospital mortality among critical care
patients with an AUROC 0.753 (95% CI, 0.750-0.757)
compared to AUROC of 0.607 (95% CI, 0.603-0.611) for
qSOFA. This study the SOFA was superior to qSOFA with
a slightly higher AUROC of 0.799 (95% CI, 0.75-0.846)
for SOFA and AUROC of 0.694 for qSOFA (95% CI, 0.6410.748). In a middle income setting of Thailand in 2018,
Khwannimit, et al. [9], showed similar higher AUROCs
with SOFA (AUROC 0.839) superior to qSOFA (AUROC
0.814). In these studies, by Seymour, et al. [10], Raith,
et al. [8] and Khwannimit, et al. [9], SOFA also showed
superiority in predicting prolonged critical care stay.
In this study, there was no difference in predicting for
prolonged critical care stay between SOFA and qSOFA,
attributed to the fewer patients with qSOFA score more
than two in this study.
This study cohort had more males than females in
keeping with similar studies by Seymour, et al. [10],
Raith, et al. [8] and Khwannimit, et al. [9]. This may be
explained by the gender difference in sepsis with males
having a higher predisposition [11]. Patients in our study
were younger with a mean age of 54 years compared
to 62 years in both Raith, et al. [8] and Khwannimit,
et al. [9]. This reflects the underlying demographic
differences in the settings with older populations in both
USA and Thailand compared to Kenya [12]. In severity of
illness, this study cohort had a comparable proportion
of patients with SOFA score of two or more compared
to the Raith, et al. [8] in Australia and New Zealand
(82.44% Vs. 90.1%) [8]. The same for qSOFA score of
two or more (42.22% Vs. 54.4%) [8]. Overall mortality
was higher in this study cohort with mortality rate of
20.44% compared to 18.7% in the Raith, et al. [8]. The
higher mortality in patients with relatively less severe
illness and younger age attributed to differences in co
morbidities with higher number of malignant disease
in this study cohort. The overall mortality rate among
this cohort of with suspected sepsis is less than the
overall critical care mortality in a public critical care unit
at Moi teaching and referral hospital, Eldoret, Kenya,
with a 53% overall critical mortality and 80% mortality
Said et al. Int J Crit Care Emerg Med 2019, 5:084
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among sepsis patients [13]. The patient to critical care
health care professionals and better access to advanced
diagnostics and critical care therapies at AKUH, N critical
care units likely explains the difference in mortality
rate. The average length of critical care stay was four
days in our cohort similar to other studies to Raith, et
al. [8], Khwannimit, et al. [9] and Seymour, et al. [10].
The overall hospital length of stay was longer in the
Khwannimit, et al. [9] cohort with an average length of
hospital stay of 16 days compared to this study cohort’s
8 days, likely due to differences in patient characteristics
with an older patient pollution in the Khwannimit, et al.
[9]. There may also be differences in care and discharge
protocols in the settings.
In comorbidities, there were significant differences
between this cohort and studies higher income countries. In Raith, et al. [8] cohort only 0.1% had HIV/AIDS
compared to 8.9% in our cohort. This reflects the differences in prevalence of HIV in Kenya at 4.8% in 2017
[14] compared to Australia and New Zealand at 0.1% in
2017 [15]. There were also more patients with diabetes (27.3% vs. 3.5%) and malignancies (16.5% vs. 3.2%)
in this cohort compared to the Raith, et al. [8] cohort.
This may reflect differences in the overall diagnosis and
management of these conditions. There is earlier diagnosis and better treatment options in the higher income countries compared to low income countries [16].
This earlier and better treatment reduces the number
of cancer patients requiring critical care admission [17].
The commonest source of infection was the respiratory system followed by urinary tract source in keeping
with Seymour, et al. [10], Raith, et al. [8] and Khwannimit, et al. [9]. There is a low MRSA prevalence in this
study at 9% compared to higher income countries, like
USA with a prevalence of 41% [18]. The MRSA prevalence of < 10% is similar to a study at AKUH, N in 2014,
that showed a prevalence of 4.8% [19] and other African
countries like in Madagascar with 4.4% [20]. The commonest organism was E. coli followed by K. pneumonia
similar to both Raith, et al. [8] and Khwannimit, et al.
[9] cohorts. We had a high proportion of prevalence of
ESBL producing bacteria among our gram-negative isolates (44.1%) compared to 2.6% in most parts of Europe
[21]. Therefore, there are distinct differences in pathogen antibiotic resistance patterns in this study cohort
compared to high-income countries. It is unclear how
this affects the patient outcomes. Further study would
be required.
This study has confirmed that a SOFA score of two
or more points within the first twenty-four hours in critical care had a good predictive for in hospital mortality. The study also demonstrated SOFA was superior to
qSOFA in predicting in hospital mortality in this cohort
of critical care patients with suspected infection at the
point of admission in a low-income country. This suggests that SOFA would be an appropriate data based starting point in diagnosing sepsis in a developing country
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population as suggested in the consensus statement of
SEPSIS 3 definition [1].
The main limitations of this study are it is from a single well-resourced center study and the retrospective
nature with missing data and excluding patients who
develop sepsis latter in to their stay in the critical care
units or patients with sepsis outside the critical care setting. This limits generalizability. We also did not explore
the uniformity of sepsis management. Improper management of sepsis may affect the outcome. We recommend further research on sepsis management and
outcomes, looking prospectively at compliance with
surviving sepsis bundles or other guideline-based sepsis
management and related outcomes.
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Conclusion

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M,
Annane D, et al. (2016) The third international consensus
definitions for sepsis and septic shock (sepsis-3). JAMA
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The present study demonstrated that among adult
patients with suspected infection at admission to critical
care, a SOFA score of two or more was better than qSOFA score of two or more in predicting in-hospital mortality. This finding suggests that SOFA is an appropriate
tool in the initial diagnosis sepsis in critical care setting
in a developing country. This is in keeping with Sepsis 3
consensus recommendation.
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